{
    "Trade/Device Name(s)": [
        "Quantia IgE"
    ],
    "Submitter Information": "Biokit, S.A.",
    "510(k) Number": "K214068",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050493"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DGC"
    ],
    "Summary Letter Date": "February 21, 2023",
    "Summary Letter Received Date": "October 31, 2022",
    "Submission Date": "October 28, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, And E Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "allergy"
    ],
    "Analyte(s)": [
        "Total immunoglobulin E (IgE)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "EDTA tube",
        "Heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c Systems",
        "ARCHITECT c8000 instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Automated latex enhanced immunoassay",
        "Turbidimetric",
        "Immunoturbidimetric"
    ],
    "Methodologies": [
        "Quantitative immunoassay",
        "Immunoturbidimetric assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Quantia IgE automated latex enhanced immunoassay for quantitative determination of total IgE using ARCHITECT c Systems",
    "Indications for Use Summary": "Automated latex enhanced immunoassay for quantitative in vitro determination of total immunoglobulin E (IgE) in human serum or plasma (EDTA, heparin, citrate) using ARCHITECT c Systems; measurement of total IgE is useful in the clinical diagnosis of IgE-mediated allergies when used with other clinical studies",
    "fda_folder": "Immunology"
}